These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16735941

  • 1. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group.
    Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
    [Abstract] [Full Text] [Related]

  • 2. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH, Speroff L, Ellman H, Dart C.
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [Abstract] [Full Text] [Related]

  • 3. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 4. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Jun; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 5. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Jun; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 6. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Jun; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 7. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N.
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [Abstract] [Full Text] [Related]

  • 8. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

  • 9. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Aug; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 10. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
    Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.
    Int J Fertil Womens Med; 2000 Aug; 45(4):264-72. PubMed ID: 10997482
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 12. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct 20; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 13. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA, Stevens RE, Ayres SA, Phelps KV.
    Climacteric; 2001 Mar 20; 4(1):19-27. PubMed ID: 11379374
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Mar 20; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 15. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar 20; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.